Clinical Trials
- Brain, Spinal Cord & Nervous System
AMS05: Ocrelizumab Discontinuation in Relapsing Multiple Sclerosis
Efficacy and safety study of frexalimab (SAR441344) in adults with nonrelapsing secondary progressive Multiple Sclerosis
- Ages18 years - 60 years
- GenderBoth
- Brain, Spinal Cord & Nervous System
Evaluating the Immune Response to COVID-19 Vaccination in B-cell Depleted Patients
- Ages18 years and older
- GenderBoth
- Brain, Spinal Cord & Nervous System
Identifying and Characterizing Preclinical MS
- Ages13 years and older
- GenderBoth
Intestinal Immunity in Neurologic Disease
- Brain, Spinal Cord & Nervous System
The Brain Shuttle Study
- Brain, Spinal Cord & Nervous System
The ExTINGUISH Trial of Inebilizumab in NMDAR Encephalitis (ExTINGUISH)
- Ages18 years and older
- GenderBoth